Organoids Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Organ Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Development of Biology Disease, Pathology of infectious Disease, Regenerative Medicines, Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, and Others), Source (Pluripotent Stem Cell and Organ Specific Adult Stem Cell), Type (Instruments, Consumables, and Services), and Geography
The organoids market is expected to grow from US$ 2.507 billion in 2022 to US$ 12.206 billion by 2030; it is estimated to register a CAGR of 21.9% from 2022 to 2030. The higher demand for tumor modeling and biobanking, growing adoption of personalized drugs, and rising focus on developing alternatives for animal testing models drive the organoids market growth. The organoids market trends include combining organoids with organ-on-a-chip.
The organoids are tiny, self-organized, three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ or to express selected aspects of it, like producing only certain types of cells. Organoids grow from stem cells—cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters.
Many market players and research institutes operating in the organoids market are developing advanced technologies to expand their product portfolios and increase their market shares. A few of the recent developments related to organoids are mentioned below:
o In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.
o In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.
Thus, the development is likely to introduce new trends in the organoids market during the forecast period.
The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.
Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study ‘CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,’ published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.
Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research.
Thus, such innovations are expected to offer more significant growth opportunities for organoids market growth.
Application-Based Insights
Based on application, the organoids market is divided into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. In 2022, the developmental biology held the largest share of the market and drug discovery & personalized medicine is anticipated to register the highest CAGR during the forecast period.
Source-Based Insights
Based on source, the organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.
The World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine are a few of the major primary and secondary sources referred to while preparing the report on the organoids market.
Type-Based Insights
Based on type, the organoids market is bifurcated into instruments, consumables, and services. The consumables segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.
The organoids are tiny, self-organized, three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ or to express selected aspects of it, like producing only certain types of cells. Organoids grow from stem cells—cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters.
Many market players and research institutes operating in the organoids market are developing advanced technologies to expand their product portfolios and increase their market shares. A few of the recent developments related to organoids are mentioned below:
o In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.
o In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.
Thus, the development is likely to introduce new trends in the organoids market during the forecast period.
The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.
Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study ‘CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,’ published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.
Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research.
Thus, such innovations are expected to offer more significant growth opportunities for organoids market growth.
Application-Based Insights
Based on application, the organoids market is divided into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. In 2022, the developmental biology held the largest share of the market and drug discovery & personalized medicine is anticipated to register the highest CAGR during the forecast period.
Source-Based Insights
Based on source, the organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.
The World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine are a few of the major primary and secondary sources referred to while preparing the report on the organoids market.
Type-Based Insights
Based on type, the organoids market is bifurcated into instruments, consumables, and services. The consumables segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ORGANOIDS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
5. ORGANOIDS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Increasing Demand for Tumor Modeling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Key Market Restraints:
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Key Market Opportunities:
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends:
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis:
6. ORGANOIDS MARKET - GLOBAL MARKET ANALYSIS
6.1 Organoids Market Revenue (US$ Mn), 2022 – 2030
7. GLOBAL ORGANOIDS MARKET – REVENUE AND FORECAST TO 2030 – BY ORGAN TYPE
7.1 Overview
7.2 Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL ORGANOIDS MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION
8.1 Overview
8.2 Organoids Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL ORGANOIDS MARKET – REVENUE AND FORECAST TO 2030 – BY SOURCE
9.1 Overview
9.2 Organoids Market Revenue Share, by Source 2022 & 2030 (%)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10. GLOBAL ORGANOIDS MARKET – REVENUE AND FORECAST TO 2030 – BY TYPE
10.1 Overview
10.2 Organoids Market Revenue Share, by Type 2022 & 2030 (%)
10.3 Instruments
10.3.1 Overview
10.3.2 Instruments: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Consumables
10.4.1 Overview
10.4.2 Consumables: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Services
10.5.1 Overview
10.5.2 Services: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
11. ORGANOIDS MARKET - GEOGRAPHICAL ANALYSIS
11.1 North America Organoids Market, Revenue And Forecast To 2030
11.1.1 Overview
11.1.2 North America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America Organoids Market, by Organ Type
11.1.4 North America Organoids Market, by Application
11.1.5 North America Organoids Market, by Source
11.1.6 North America Organoids Market, by Type
11.1.7 North America Organoids Market, by Country
11.1.7.1 US
11.1.7.1.1 Overview
11.1.7.1.2 US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.1.3 US Organoids Market, by Organ Type
11.1.7.1.4 US Organoids Market, by Application
11.1.7.1.5 US Organoids Market, by Source
11.1.7.1.6 US Organoids Market, by Type
11.1.7.2 Canada
11.1.7.2.1 Overview
11.1.7.2.2 Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.2.3 Canada Organoids Market, by Organ Type
11.1.7.2.4 Canada Organoids Market, by Application
11.1.7.2.5 Canada Organoids Market, by Source
11.1.7.2.6 Canada Organoids Market, by Type
11.1.7.3 Mexico
11.1.7.3.1 Overview
11.1.7.3.2 Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.3.3 Mexico Organoids Market, by Organ Type
11.1.7.3.4 Mexico Organoids Market, by Application
11.1.7.3.5 Mexico Organoids Market, by Source
11.1.7.3.6 Mexico Organoids Market, by Type
11.2 Europe Organoids Market, Revenue And Forecast to 2030
11.2.1 Overview
11.2.2 Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe Organoids Market, by Organ Type
11.2.4 Europe Organoids Market, by Application
11.2.5 Europe Organoids Market, by Source
11.2.6 Europe Organoids Market, by Type
11.2.7 Europe Organoids Market by Country
11.2.7.1 Germany
11.2.7.1.1 Overview
11.2.7.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.1.3 Germany Organoids Market, by Organ Type
11.2.7.1.4 Germany Organoids Market, by Application
11.2.7.1.5 Germany Organoids Market, by Source
11.2.7.1.6 Germany Organoids Market, by Type
11.2.7.2 UK
11.2.7.2.1 Overview
11.2.7.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.2.3 UK Organoids Market, by Organ Type
11.2.7.2.4 UK Organoids Market, by Application
11.2.7.2.5 UK Organoids Market, by Source
11.2.7.2.6 UK Organoids Market, by Type
11.2.7.3 France
11.2.7.3.1 Overview
11.2.7.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.3.3 France Organoids Market, by Organ Type
11.2.7.3.4 France Organoids Market, by Application
11.2.7.3.5 France Organoids Market, by Source
11.2.7.3.6 France Organoids Market, by Type
11.2.7.4 Italy
11.2.7.4.1 Overview
11.2.7.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.4.3 Italy Organoids Market, by Organ Type
11.2.7.4.4 Italy Organoids Market, by Application
11.2.7.4.5 Italy Organoids Market, by Source
11.2.7.4.6 Italy Organoids Market, by Type
11.2.7.5 Spain
11.2.7.5.1 Overview
11.2.7.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.5.3 Spain Organoids Market, by Organ Type
11.2.7.5.4 Spain Organoids Market, by Application
11.2.7.5.5 Spain Organoids Market, by Source
11.2.7.5.6 Spain Organoids Market, by Type
11.2.7.6 Rest of Europe
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.6.3 Rest of Europe Organoids Market, by Organ Type
11.2.7.6.4 Rest of Europe Organoids Market, by Application
11.2.7.6.5 Rest of Europe Organoids Market, by Source
11.2.7.6.6 Rest of Europe Organoids Market, by Type
11.3 Asia Pacific Organoids Market, Revenue And Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific Organoids Market, by Organ Type
11.3.4 Asia Pacific Organoids Market, by Application
11.3.5 Asia Pacific Organoids Market, by Source
11.3.6 Asia Pacific Organoids Market, by Type
11.3.7 Asia Pacific Organoids Market by Country
11.3.7.1 China
11.3.7.1.1 Overview
11.3.7.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.1.3 China Organoids Market, by Organ Type
11.3.7.1.4 China Organoids Market, by Application
11.3.7.1.5 China Organoids Market, by Source
11.3.7.1.6 China Organoids Market, by Type
11.3.7.2 Japan
11.3.7.2.1 Overview
11.3.7.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.2.3 Japan Organoids Market, by Organ Type
11.3.7.2.4 Japan Organoids Market, by Application
11.3.7.2.5 Japan Organoids Market, by Source
11.3.7.2.6 Japan Organoids Market, by Type
11.3.7.3 India
11.3.7.3.1 Overview
11.3.7.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.3.3 India Organoids Market, by Organ Type
11.3.7.3.4 India Organoids Market, by Application
11.3.7.3.5 India Organoids Market, by Source
11.3.7.3.6 India Organoids Market, by Type
11.3.7.4 Australia
11.3.7.4.1 Overview
11.3.7.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.4.3 Australia Organoids Market, by Organ Type
11.3.7.4.4 Australia Organoids Market, by Application
11.3.7.4.5 Australia Organoids Market, by Source
11.3.7.4.6 Australia Organoids Market, by Type
11.3.7.5 South Korea
11.3.7.5.1 Overview
11.3.7.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.5.3 South Korea Organoids Market, by Organ Type
11.3.7.5.4 South Korea Organoids Market, by Application
11.3.7.5.5 South Korea Organoids Market, by Source
11.3.7.5.6 South Korea Organoids Market, by Type
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.6.3 Rest of Asia Pacific Organoids Market, by Organ Type
11.3.7.6.4 Rest of Asia Pacific Organoids Market, by Application
11.3.7.6.5 Rest of Asia Pacific Organoids Market, by Source
11.3.7.6.6 Rest of Asia Pacific Organoids Market, by Type
11.4 Middle East & Africa Organoids Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa Organoids Market, by Organ Type
11.4.4 Middle East & Africa Organoids Market, by Application
11.4.5 Middle East & Africa Organoids Market, by Source
11.4.6 Middle East & Africa Organoids Market, by Type
11.4.7 Middle East & Africa Organoids Market by Country
11.4.7.1 Saudi Arabia
11.4.7.1.1 Overview
11.4.7.1.2 Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.1.3 Saudi Arabia Organoids Market, by Organ Type
11.4.7.1.4 Saudi Arabia Organoids Market, by Application
11.4.7.1.5 Saudi Arabia Organoids Market, by Source
11.4.7.1.6 Saudi Arabia Organoids Market, by Type
11.4.7.2 UAE
11.4.7.2.1 Overview
11.4.7.2.2 UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.2.3 UAE Organoids Market, by Organ Type
11.4.7.2.4 UAE Organoids Market, by Application
11.4.7.2.5 UAE Organoids Market, by Source
11.4.7.2.6 UAE Organoids Market, by Type
11.4.7.3 South Africa
11.4.7.3.1 Overview
11.4.7.3.2 South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.3.3 South Africa Organoids Market, by Organ Type
11.4.7.3.4 South Africa Organoids Market, by Application
11.4.7.3.5 South Africa Organoids Market, by Source
11.4.7.3.6 South Africa Organoids Market, by Type
11.4.7.4 Rest of Middle East & Africa
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.4.3 Rest of Middle East & Africa Organoids Market, by Organ Type
11.4.7.4.4 Rest of Middle East & Africa Organoids Market, by Application
11.4.7.4.5 Rest of Middle East & Africa Organoids Market, by Source
11.4.7.4.6 Rest of Middle East & Africa Organoids Market, by Type
11.5 South & Central America Organoids Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America Organoids Market, by Organ Type
11.5.4 South & Central America Organoids Market, by Application
11.5.5 South & Central America Organoids Market, by Source
11.5.6 South & Central America Organoids Market, by Type
11.5.7 South & Central America Organoids Market by Country
11.5.7.1 Brazil
11.5.7.1.1 Overview
11.5.7.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.1.3 Brazil Organoids Market, by Organ Type
11.5.7.1.4 Brazil Organoids Market, by Application
11.5.7.1.5 Brazil Organoids Market, by Source
11.5.7.1.6 Brazil Organoids Market, by Type
11.5.7.2 Argentina
11.5.7.2.1 Overview
11.5.7.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.2.3 Argentina Organoids Market, by Organ Type
11.5.7.2.4 Argentina Organoids Market, by Application
11.5.7.2.5 Argentina Organoids Market, by Source
11.5.7.2.6 Argentina Organoids Market, by Type
11.5.7.3 Rest of South & Central America
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.3.3 Rest of South & Central America Organoids Market, by Organ Type
11.5.7.3.4 Rest of South & Central America Organoids Market, by Application
11.5.7.3.5 Rest of South & Central America Organoids Market, by Source
11.5.7.3.6 Rest of South & Central America Organoids Market, by Type
12. PRE & POST COVID-19 IMPACT
12.1 Pre & Post Covid-19 Impact
13. ORGANOIDS MARKET INDUSTRY LANDSCAPE
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. ORGANOIDS MARKET, KEY COMPANY PROFILES
14.1 STEMCELL Technologies Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Cellesce Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Hubrecht Organoid Technology
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Definigen
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Organoid Therapeutics
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 3Dnamics Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Thermo Fisher Scientific Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Corning Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Merck KGaA
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 InSphero
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About Us
15.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ORGANOIDS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
5. ORGANOIDS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers:
5.1.1 Increasing Demand for Tumor Modeling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Key Market Restraints:
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Key Market Opportunities:
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends:
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis:
6. ORGANOIDS MARKET - GLOBAL MARKET ANALYSIS
6.1 Organoids Market Revenue (US$ Mn), 2022 – 2030
7. GLOBAL ORGANOIDS MARKET – REVENUE AND FORECAST TO 2030 – BY ORGAN TYPE
7.1 Overview
7.2 Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL ORGANOIDS MARKET – REVENUE AND FORECAST TO 2030 – BY APPLICATION
8.1 Overview
8.2 Organoids Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL ORGANOIDS MARKET – REVENUE AND FORECAST TO 2030 – BY SOURCE
9.1 Overview
9.2 Organoids Market Revenue Share, by Source 2022 & 2030 (%)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10. GLOBAL ORGANOIDS MARKET – REVENUE AND FORECAST TO 2030 – BY TYPE
10.1 Overview
10.2 Organoids Market Revenue Share, by Type 2022 & 2030 (%)
10.3 Instruments
10.3.1 Overview
10.3.2 Instruments: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Consumables
10.4.1 Overview
10.4.2 Consumables: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Services
10.5.1 Overview
10.5.2 Services: Organoids Market – Revenue and Forecast to 2030 (US$ Million)
11. ORGANOIDS MARKET - GEOGRAPHICAL ANALYSIS
11.1 North America Organoids Market, Revenue And Forecast To 2030
11.1.1 Overview
11.1.2 North America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America Organoids Market, by Organ Type
11.1.4 North America Organoids Market, by Application
11.1.5 North America Organoids Market, by Source
11.1.6 North America Organoids Market, by Type
11.1.7 North America Organoids Market, by Country
11.1.7.1 US
11.1.7.1.1 Overview
11.1.7.1.2 US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.1.3 US Organoids Market, by Organ Type
11.1.7.1.4 US Organoids Market, by Application
11.1.7.1.5 US Organoids Market, by Source
11.1.7.1.6 US Organoids Market, by Type
11.1.7.2 Canada
11.1.7.2.1 Overview
11.1.7.2.2 Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.2.3 Canada Organoids Market, by Organ Type
11.1.7.2.4 Canada Organoids Market, by Application
11.1.7.2.5 Canada Organoids Market, by Source
11.1.7.2.6 Canada Organoids Market, by Type
11.1.7.3 Mexico
11.1.7.3.1 Overview
11.1.7.3.2 Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.3.3 Mexico Organoids Market, by Organ Type
11.1.7.3.4 Mexico Organoids Market, by Application
11.1.7.3.5 Mexico Organoids Market, by Source
11.1.7.3.6 Mexico Organoids Market, by Type
11.2 Europe Organoids Market, Revenue And Forecast to 2030
11.2.1 Overview
11.2.2 Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe Organoids Market, by Organ Type
11.2.4 Europe Organoids Market, by Application
11.2.5 Europe Organoids Market, by Source
11.2.6 Europe Organoids Market, by Type
11.2.7 Europe Organoids Market by Country
11.2.7.1 Germany
11.2.7.1.1 Overview
11.2.7.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.1.3 Germany Organoids Market, by Organ Type
11.2.7.1.4 Germany Organoids Market, by Application
11.2.7.1.5 Germany Organoids Market, by Source
11.2.7.1.6 Germany Organoids Market, by Type
11.2.7.2 UK
11.2.7.2.1 Overview
11.2.7.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.2.3 UK Organoids Market, by Organ Type
11.2.7.2.4 UK Organoids Market, by Application
11.2.7.2.5 UK Organoids Market, by Source
11.2.7.2.6 UK Organoids Market, by Type
11.2.7.3 France
11.2.7.3.1 Overview
11.2.7.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.3.3 France Organoids Market, by Organ Type
11.2.7.3.4 France Organoids Market, by Application
11.2.7.3.5 France Organoids Market, by Source
11.2.7.3.6 France Organoids Market, by Type
11.2.7.4 Italy
11.2.7.4.1 Overview
11.2.7.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.4.3 Italy Organoids Market, by Organ Type
11.2.7.4.4 Italy Organoids Market, by Application
11.2.7.4.5 Italy Organoids Market, by Source
11.2.7.4.6 Italy Organoids Market, by Type
11.2.7.5 Spain
11.2.7.5.1 Overview
11.2.7.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.5.3 Spain Organoids Market, by Organ Type
11.2.7.5.4 Spain Organoids Market, by Application
11.2.7.5.5 Spain Organoids Market, by Source
11.2.7.5.6 Spain Organoids Market, by Type
11.2.7.6 Rest of Europe
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.6.3 Rest of Europe Organoids Market, by Organ Type
11.2.7.6.4 Rest of Europe Organoids Market, by Application
11.2.7.6.5 Rest of Europe Organoids Market, by Source
11.2.7.6.6 Rest of Europe Organoids Market, by Type
11.3 Asia Pacific Organoids Market, Revenue And Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific Organoids Market, by Organ Type
11.3.4 Asia Pacific Organoids Market, by Application
11.3.5 Asia Pacific Organoids Market, by Source
11.3.6 Asia Pacific Organoids Market, by Type
11.3.7 Asia Pacific Organoids Market by Country
11.3.7.1 China
11.3.7.1.1 Overview
11.3.7.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.1.3 China Organoids Market, by Organ Type
11.3.7.1.4 China Organoids Market, by Application
11.3.7.1.5 China Organoids Market, by Source
11.3.7.1.6 China Organoids Market, by Type
11.3.7.2 Japan
11.3.7.2.1 Overview
11.3.7.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.2.3 Japan Organoids Market, by Organ Type
11.3.7.2.4 Japan Organoids Market, by Application
11.3.7.2.5 Japan Organoids Market, by Source
11.3.7.2.6 Japan Organoids Market, by Type
11.3.7.3 India
11.3.7.3.1 Overview
11.3.7.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.3.3 India Organoids Market, by Organ Type
11.3.7.3.4 India Organoids Market, by Application
11.3.7.3.5 India Organoids Market, by Source
11.3.7.3.6 India Organoids Market, by Type
11.3.7.4 Australia
11.3.7.4.1 Overview
11.3.7.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.4.3 Australia Organoids Market, by Organ Type
11.3.7.4.4 Australia Organoids Market, by Application
11.3.7.4.5 Australia Organoids Market, by Source
11.3.7.4.6 Australia Organoids Market, by Type
11.3.7.5 South Korea
11.3.7.5.1 Overview
11.3.7.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.5.3 South Korea Organoids Market, by Organ Type
11.3.7.5.4 South Korea Organoids Market, by Application
11.3.7.5.5 South Korea Organoids Market, by Source
11.3.7.5.6 South Korea Organoids Market, by Type
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.6.3 Rest of Asia Pacific Organoids Market, by Organ Type
11.3.7.6.4 Rest of Asia Pacific Organoids Market, by Application
11.3.7.6.5 Rest of Asia Pacific Organoids Market, by Source
11.3.7.6.6 Rest of Asia Pacific Organoids Market, by Type
11.4 Middle East & Africa Organoids Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa Organoids Market, by Organ Type
11.4.4 Middle East & Africa Organoids Market, by Application
11.4.5 Middle East & Africa Organoids Market, by Source
11.4.6 Middle East & Africa Organoids Market, by Type
11.4.7 Middle East & Africa Organoids Market by Country
11.4.7.1 Saudi Arabia
11.4.7.1.1 Overview
11.4.7.1.2 Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.1.3 Saudi Arabia Organoids Market, by Organ Type
11.4.7.1.4 Saudi Arabia Organoids Market, by Application
11.4.7.1.5 Saudi Arabia Organoids Market, by Source
11.4.7.1.6 Saudi Arabia Organoids Market, by Type
11.4.7.2 UAE
11.4.7.2.1 Overview
11.4.7.2.2 UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.2.3 UAE Organoids Market, by Organ Type
11.4.7.2.4 UAE Organoids Market, by Application
11.4.7.2.5 UAE Organoids Market, by Source
11.4.7.2.6 UAE Organoids Market, by Type
11.4.7.3 South Africa
11.4.7.3.1 Overview
11.4.7.3.2 South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.3.3 South Africa Organoids Market, by Organ Type
11.4.7.3.4 South Africa Organoids Market, by Application
11.4.7.3.5 South Africa Organoids Market, by Source
11.4.7.3.6 South Africa Organoids Market, by Type
11.4.7.4 Rest of Middle East & Africa
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.4.3 Rest of Middle East & Africa Organoids Market, by Organ Type
11.4.7.4.4 Rest of Middle East & Africa Organoids Market, by Application
11.4.7.4.5 Rest of Middle East & Africa Organoids Market, by Source
11.4.7.4.6 Rest of Middle East & Africa Organoids Market, by Type
11.5 South & Central America Organoids Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America Organoids Market, by Organ Type
11.5.4 South & Central America Organoids Market, by Application
11.5.5 South & Central America Organoids Market, by Source
11.5.6 South & Central America Organoids Market, by Type
11.5.7 South & Central America Organoids Market by Country
11.5.7.1 Brazil
11.5.7.1.1 Overview
11.5.7.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.1.3 Brazil Organoids Market, by Organ Type
11.5.7.1.4 Brazil Organoids Market, by Application
11.5.7.1.5 Brazil Organoids Market, by Source
11.5.7.1.6 Brazil Organoids Market, by Type
11.5.7.2 Argentina
11.5.7.2.1 Overview
11.5.7.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.2.3 Argentina Organoids Market, by Organ Type
11.5.7.2.4 Argentina Organoids Market, by Application
11.5.7.2.5 Argentina Organoids Market, by Source
11.5.7.2.6 Argentina Organoids Market, by Type
11.5.7.3 Rest of South & Central America
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.3.3 Rest of South & Central America Organoids Market, by Organ Type
11.5.7.3.4 Rest of South & Central America Organoids Market, by Application
11.5.7.3.5 Rest of South & Central America Organoids Market, by Source
11.5.7.3.6 Rest of South & Central America Organoids Market, by Type
12. PRE & POST COVID-19 IMPACT
12.1 Pre & Post Covid-19 Impact
13. ORGANOIDS MARKET INDUSTRY LANDSCAPE
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. ORGANOIDS MARKET, KEY COMPANY PROFILES
14.1 STEMCELL Technologies Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Cellesce Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Hubrecht Organoid Technology
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Definigen
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Organoid Therapeutics
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 3Dnamics Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Thermo Fisher Scientific Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Corning Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Merck KGaA
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 InSphero
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About Us
15.2 Glossary of Terms
